Nicholas Shorts
-
News
Boosting The Pharma Innovations with The Help of Omnibus Bill
The federal government is planning to chill out guidelines on drug patents within the omnibus bill on job creation to…
Read More » -
News
Nixed Deal Ends the Alliance of Two Big Pharmas
Pfizer and Merck are every chopping ties with smaller medical-stage biotech after experimental medication being developed underneath separate alliances fell…
Read More » -
News
Pharmas Are Keeping an Eye On All the Chinese Imports
The Pharmaceuticals Export Promotion Council of India is reaching out to drugmakers, in search of particulars of lively pharmaceutical components…
Read More » -
News
New Drug Discovered May Help Against Memory Loss in Alzheimer’s Disease
A new drug discovered through an analysis collaboration between the University at Buffalo and Tetra Therapeutics could shield against memory…
Read More » -
News
FDA Has Fast Track Designation for The Development of Farxiga (Dapagliflozin)
The F.D.A. has awarded Fast Track designation for the development of AstraZeneca – Farxiga (dapagliflozin) to delay the progressions of…
Read More » -
News
Astrazeneca Announced Positive Results from The Landmark Part III DAPA-HF Trial
AstraZeneca announced positive results from the landmark Part III DAPA-HF trial which confirmed that Farxiga (dapagliflozin) met the primary composite…
Read More » -
News
FDA Approved Pretomanid Tablets in Combination with Bedaquiline and Linezolid for TB
The US Food and Drug Administration authorized Pretomanid Tablets in combination with bedaquiline and linezolid for the remedy of a…
Read More » -
News
Bayer AG Buys BlueRock Therapeutics to Modify Cell Therapy
Bayer AG and BlueRock Therapeutics declared an agreement under which Bayer will acquire BlueRock Therapeutics, a privately held US-headquartered biotechnology…
Read More » -
News
FDA Approved Turalio Capsules for Treatment of Tenosynovial Giant Cell Tumor
The Food and Drug Administration approved Turalio (pexidartinib) capsules for the treatment of adult sufferers with symptomatic tenosynovial giant cell…
Read More » -
News
Price Tag for A Life Costs – $2.1 Million
When the Food and Drug Administration (FDA) accepted Zolgensma, a lifesaving medication to treat spinal muscular atrophy, parents of younger kids…
Read More »